Therapy (HCV)
"High Levels of Serum Interleukin-10 Are Associated with a Poor Response to Interferon Treatment in Patients with Chronic Hepatitis C."
Published in Hepatitis Weekly, March 24th, 1997
According to the authors' abstract of an article published in Scandinavian Journal of Gastroenterology, "Background: It still remains unclear whether some immunologic factors affect the response to interferon treatment. We therefore examined whether the pretreatment levels of serum interleukin-10 and soluble intercellular adhesion molecule-1 can be associated with the response to interferon treatment in patients with chronic hepatitis C. Methods: One hundred and two patients with chronic hepatitis C treated with interferon alpha-2b were divided into three groups on the basis of patterns of biochemical interferon response. Pretreatment levels of serum interleukin-10 and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1997-03-24)
More Articles from Hepatitis Weekly
- Therapy (HCV)
IFN-(alpha)n3 Appears Useful in Treating Hepatitis C - Blood Banking (Safety)
GAO: "Blood Supply is Very Safe" - Blood Banking (Screening)
Blood Banks Should be Accountable to Donors - Diagnostics (HCV)
Current Assays Don't Detect Mixed Infections in Hemophiliacs - Epidemiology
Acute non-ABCDE Disease More Severe than Acute HCV - HAV Vaccines
Vaccine Gaining in Popularity in Food Industry - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
